Molecular characterization of acute myeloid leukemia and its impact on treatment

Olga Frankfurt*, Jonathan D. Licht, Martin S. Tallman

*Corresponding author for this work

Research output: Contribution to journalReview articlepeer-review

24 Scopus citations


PURPOSE OF REVIEW: Molecular aberrations are playing an ever increasing role in guiding classification, prognosis, and therapeutic strategies in patients with acute myeloid leukemia. This review outlines recent strides in our understanding of the molecular characteristics of acute myeloid leukemia. RECENT FINDINGS: We highlight the novel concept of preferential co-expression of certain mutations, summarize recent data on the clinically relevant prognostic role of known and novel molecular aberrations, and emphasize the emerging role of gene expression profiling and minimal residual disease monitoring. SUMMARY: We review the molecular heterogeneity within already established categories of acute myeloid leukemia and discuss how these data may translate into prognostic, molecular-based therapy stratification to improve patient outcome.

Original languageEnglish (US)
Pages (from-to)635-649
Number of pages15
JournalCurrent opinion in oncology
Issue number6
StatePublished - Nov 2007


  • Acute myeloid leukemia
  • Acute promyelocytic leukemia
  • Core-binding factor leukemia
  • Cytogenetically normal acute myeloid leukemia
  • Cytogenetics
  • Molecular analysis

ASJC Scopus subject areas

  • Oncology
  • Cancer Research


Dive into the research topics of 'Molecular characterization of acute myeloid leukemia and its impact on treatment'. Together they form a unique fingerprint.

Cite this